Primary Tumor Resection in Colorectal Cancer with Unresectable Synchronous Metastasis: Time to Reconsider the Role of the Surgeon Tsuyoshi KonishiMiguel A. Rodriguez-Bigas ASO Perspectives 20 October 2021 Pages: 1 - 3
Solving for Chemotherapeutic Sensitivity: Adapting “Black Box” Methods to Study Patient-Derived Tumor Organoids Toni T. SeppäläJacquelyn W. ZimmermanRichard A. Burkhart Translational Research 28 October 2021 Pages: 4 - 6
Medullary Thyroid Cancer: 60 Years of Gradual Understanding Gerard M. Doherty Endocrine Tumors 10 November 2021 Pages: 7 - 8
Invited Editorial: Does Side Really Matter? Survival Analysis Among Patients with Right- Versus Left-Sided Colon Cancer: A Propensity Score-Adjusted Analysis Austin J. LivingstonChristina E. Bailey Colorectal Cancer 24 September 2021 Pages: 9 - 10
Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer Sonal S. NoticewalaPrajnan Das Colorectal Cancer 06 October 2021 Pages: 11 - 12
Is PIPAC a New Summit for Peritoneal Disease Treatment or are we Lost in the Snowstorm? Brian Badgwell Peritoneal Surface Malignancy 12 October 2021 Pages: 13 - 14
Caveat Emptor: 2-Year Follow-Up Evaluating Post-Resection Liver Decompensation in Patients with Underlying Cirrhosis and Incident Hepatocellular Carcinoma Dhavan ShahBona KoDavid J. Bentrem Hepatobiliary Tumors 15 October 2021 Pages: 15 - 16
Improved Access to Healthcare is Good for Everyone Charles R. ScogginsMichael E. Egger Pancreatic Tumors 17 September 2021 Pages: 17 - 19
Is Margin Status Less Prognostic After Neoadjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma? John A. WindsorMark P. Callery Pancreatic Tumors 15 October 2021 Pages: 20 - 22
Editorial on Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis Abhishek Chatterjee Breast Oncology 09 October 2021 Pages: 23 - 24
Financial Toxicity Following Post-Mastectomy Reconstruction: Consideration for a Novel Outcome Measure Evan MatrosAnaeze C. Offodile II Reconstructive Oncology 15 September 2021 Pages: 25 - 27
Segmentectomy…Because We Can or Because We Should? Justin M. Karush Thoracic Oncology 21 October 2021 Pages: 28 - 29
Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody Alexander J. RossiTahsin M. KhanJonathan M. Hernandez ASO Research Letter 11 June 2021 Pages: 30 - 32
Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma Emily A. VerbusAlexander J. RossiJonathan M. Hernandez ASO Research Letter 11 June 2021 Pages: 33 - 34
Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma Alexander J. RossiTahsin M. KhanJonathan M. Hernandez ASO Research Letter 11 June 2021 Pages: 35 - 36
Perioperative Versus Adjuvant Chemotherapy in the Management of Incidentally Found Gallbladder Cancer (OPT-IN) Tahsin M. KhanEmily A. VerbusJonathan M. Hernandez ASO Research Letter 16 June 2021 Pages: 37 - 38
No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ Susie X. SunRyan SukAshish A. Deshmukh ASO Research Letter 01 September 2021 Pages: 39 - 41
The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research Joshua HerbDavid W. OllilaKaryn Stitzenberg ASO Research Letter 12 June 2021 Pages: 42 - 44
Hospital Price Transparency Rules are Inadequate to Inform Patients Needing Major Gastrointestinal Cancer Operations Joshua HerbBrittney WilliamsKaryn Stitzenberg ASO Research Letter 06 June 2021 Pages: 45 - 46
Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review Michael FloodVignesh NarasimhanAlexander Heriot Translational Research 01 October 2021 Pages: 47 - 59
ASO Author Reflections: Organoid-Based Precision Medicine in Colorectal Cancer—Are We There Yet? Michael FloodRobert RamsayAlexander Heriot ASO Author Reflections 20 September 2021 Pages: 60 - 61
ASO Visual Abstract: Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer—A Systematic Review Michael FloodVignesh NarasimhanAlexander Heriot ASO Visual Abstract 18 October 2021 Pages: 62 - 63
Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy Nicholas L. KesbyAlexander J. PapachristosAnthony R. Glover Endocrine Tumors 29 October 2021 Pages: 64 - 71
ASO Author Reflections: Medullary Thyroid Cancer—Establishing Treatment Paradigms in a Rapidly Evolving Therapeutic Landscape Alexander J. PapachristosAnthony R. GloverStan B. Sidhu ASO Author Reflections 05 November 2021 Pages: 72 - 73
ASO Visual Abstract: Outcomes of Advanced MTC in the Era of Targeted Therapy Nicholas L. KesbyAlexander J. PapachristosAnthony R. Glover ASO Visual Abstract 08 November 2021 Pages: 74 - 74
Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection Catherine G. TranScott K. ShermanJames R. Howe Endocrine Tumors 13 September 2021 Pages: 75 - 84
ASO Author Reflections: Endoscopic Management is Reasonable for <2 cm Duodenal Neuroendocrine Tumors Catherine G. TranScott K. ShermanJames R. Howe ASO Author Reflections 04 October 2021 Pages: 85 - 86
ASO Visual Abstract: Management of Duodenal Neuroendocrine Tumors—Surgical Versus Endoscopic Mucosal Resection Catherine G. TranScott K. ShermanJames R. Howe ASO Visual Abstract 20 October 2021 Pages: 87 - 87
Thyroglobulin Measurement Through Fine-Needle Aspiration for Optimizing Neck Node Dissection in Papillary Thyroid Cancer Xi JiaYuanbo WangRui Gao Endocrine Tumors Open access 12 August 2021 Pages: 88 - 96
ASO Author Reflection: Optimizing Lateral Neck Dissection Extent of PTC by FNA-Tg Xi JiaRunyi TaoRui Gao ASO Author Reflections Open access 12 August 2021 Pages: 97 - 98
Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer of Patients with Prior Pelvic Irradiation Shigeru YamadaHirotoshi Takiyamafor the Working Group on Locally Recurrent Rectal Cancer Colorectal Cancer Open access 18 October 2021 Pages: 99 - 106
ASO Visual Abstract: Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer in Patients with Prior Pelvic Irradiation Shigeru YamadaHirotoshi Takiyamafor the Working Group on Locally Recurrent Rectal Cancer ASO Visual Abstract Open access 25 October 2021 Pages: 107 - 108
Laparoscopic Extraperitoneal Approach to Bilateral Pelvic Lymph Node Dissection in Low Rectal Cancer: Technique with Video and 3D Modeling F. DumontT. BarreteauC. Loaec Colorectal Cancer 19 October 2021 Pages: 109 - 111
Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer Rémy SindayigayaCan DoganUrs Giger-Pabst Peritoneal Surface Malignancy 05 October 2021 Pages: 112 - 123
ASO Visual Abstract: Clinical Outcome of Patients Managed with Low-Dose Cisplatin and Doxorubicin delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer Rémy SindayigayaCan DoganUrs Giger-Pabst ASO Visual Abstract 15 November 2021 Pages: 124 - 125
A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei Álvaro Arjona-SánchezAna Martínez-LópezAntonio Romero-Ruíz Peritoneal Surface Malignancy 02 July 2021 Pages: 126 - 136
ASO Author Reflections: Towards a Precision Medicine in Pseudomyxoma Peritonei Álvaro Arjona-SánchezAna Martínez-LópezAntonio Romero-Ruíz ASO Author Reflections 12 July 2021 Pages: 137 - 138
HIPEC-Induced Acute Kidney Injury: A Retrospective Clinical Study and Preclinical Model Lukas F. LiesenfeldBenedikt WagnerMartin Schneider Peritoneal Surface Malignancy Open access 14 July 2021 Pages: 139 - 151
Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study Annika KurreckFelix GronauLinda Feldbrügge Peritoneal Surface Malignancy Open access 04 August 2021 Pages: 152 - 162
Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy June S. PengJessica LaPianoValerie A. Francescutti Peritoneal Surface Malignancy 12 August 2021 Pages: 163 - 173
ASO Author Reflections: Opportunities for Improving HIPEC Outcomes June S. PengValerie A. Francescutti ASO Author Reflections 28 September 2021 Pages: 174 - 174
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial Mustafa RaoofGautam MalhotraThanh H. Dellinger Peritoneal Surface Malignancy 13 August 2021 Pages: 175 - 185
ASO Author Reflections: Defining the Role of PIPAC in the Treatment of Peritoneal Metastases Mustafa RaoofThanh Dellinger ASO Author Reflections 26 July 2021 Pages: 186 - 187
Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alfonso García-FadriqueRafael Estevan EstevanLuis Sabater Ortí Peritoneal Surface Malignancy 25 August 2021 Pages: 188 - 202
ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases—Is It Time to Audit Our Results? Alfonso García-Fadrique ASO Author Reflections 25 August 2021 Pages: 203 - 204
Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy Christopher W. MangieriCristian D. ValenzuelaEdward A. Levine Peritoneal Surface Malignancy 28 August 2021 Pages: 205 - 211
ASO Author Reflections: Evaluating Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Christopher W. MangieriEdward A. Levine ASO Author Reflections 01 September 2021 Pages: 212 - 213
Bowel Anastomosis After or Before HIPEC: A Comparative Study in Patients Undergoing CRS+HIPEC for Peritoneal Surface Malignancy S. P. SomashekharKumar C. RohitK. R. Ashwin Peritoneal Surface Malignancy 30 August 2021 Pages: 214 - 223
Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS and Oesophagectomy Krishna MoorthyLaura Halliday Gastrointestinal Oncology Open access 19 October 2021 Pages: 224 - 228
Pathological N3 Stage (pN3/ypN3) Gastric Cancer: Outcomes, Prognostic Factors and Pattern of Recurrences After Curative Treatment Anadi PachauryVikram ChaudhariManish S. Bhandare Gastrointestinal Oncology 20 July 2021 Pages: 229 - 239